1. Home
  2. DARE vs AWRE Comparison

DARE vs AWRE Comparison

Compare DARE & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • AWRE
  • Stock Information
  • Founded
  • DARE N/A
  • AWRE 1986
  • Country
  • DARE United States
  • AWRE United States
  • Employees
  • DARE N/A
  • AWRE N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • DARE Health Care
  • AWRE Technology
  • Exchange
  • DARE Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • DARE 31.9M
  • AWRE 35.2M
  • IPO Year
  • DARE N/A
  • AWRE 1996
  • Fundamental
  • Price
  • DARE $3.34
  • AWRE $1.66
  • Analyst Decision
  • DARE Strong Buy
  • AWRE
  • Analyst Count
  • DARE 4
  • AWRE 0
  • Target Price
  • DARE $20.33
  • AWRE N/A
  • AVG Volume (30 Days)
  • DARE 37.5K
  • AWRE 92.3K
  • Earning Date
  • DARE 11-14-2024
  • AWRE 03-11-2025
  • Dividend Yield
  • DARE N/A
  • AWRE N/A
  • EPS Growth
  • DARE N/A
  • AWRE N/A
  • EPS
  • DARE N/A
  • AWRE N/A
  • Revenue
  • DARE $1,881,316.00
  • AWRE $16,966,000.00
  • Revenue This Year
  • DARE N/A
  • AWRE $10.98
  • Revenue Next Year
  • DARE $136.52
  • AWRE N/A
  • P/E Ratio
  • DARE N/A
  • AWRE N/A
  • Revenue Growth
  • DARE 88.13
  • AWRE N/A
  • 52 Week Low
  • DARE $2.67
  • AWRE $1.35
  • 52 Week High
  • DARE $7.56
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • DARE 52.30
  • AWRE 52.69
  • Support Level
  • DARE $3.03
  • AWRE $1.58
  • Resistance Level
  • DARE $3.38
  • AWRE $1.73
  • Average True Range (ATR)
  • DARE 0.12
  • AWRE 0.14
  • MACD
  • DARE 0.02
  • AWRE 0.00
  • Stochastic Oscillator
  • DARE 88.57
  • AWRE 27.27

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: